The global helicobacter pylori diagnostics market was valued at $552.7 million in 2022, and is projected to reach $926.8 million by 2032, growing at a CAGR of 5.3% from 2023 to 2032.
Report Code : A03203 | Pages : 261 | Category : Life Sciences
Helicobacter pylori (H. pylori) non-invasive testing is primarily used for an infection in the body when an H. pylori bacterium infects an individual's stomach. H. pylori is a spiral-shaped gram-negative aerobic bacterium developed in the digestive tract and has susceptibility to infect the stomach.
Report Code : A15396 | Category : Life Sciences
